$6.21 Billion is the total value of Bellevue Group AG's 196 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 14.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARGX | Sell | ARGENX SEsponsored adr | $448,135,494 | +24.5% | 911,530 | -1.3% | 7.22% | +40.7% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $418,840,632 | +8.8% | 9,233,700 | -1.6% | 6.75% | +22.9% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $348,691,069 | -9.7% | 1,002,735 | -8.6% | 5.62% | +2.0% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $290,649,375 | +18.0% | 2,583,550 | -1.1% | 4.68% | +33.2% |
| ISRG | Sell | INTUITIVE SURGICAL INC | $242,308,117 | -15.9% | 828,999 | -1.6% | 3.90% | -5.0% |
| ITCI | Sell | INTRA-CELLULAR THERAPIES INC | $165,138,323 | -18.5% | 3,170,250 | -1.0% | 2.66% | -8.0% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $158,388,500 | -7.3% | 894,345 | -0.6% | 2.55% | +4.7% |
| MRNA | Sell | MODERNA INC | $154,452,120 | -16.6% | 1,495,325 | -1.9% | 2.49% | -5.9% |
| ABT | Sell | ABBOTT LABS | $151,179,751 | -15.8% | 1,560,968 | -5.2% | 2.44% | -4.8% |
| INCY | Sell | INCYTE CORP | $143,931,067 | -12.4% | 2,491,450 | -5.7% | 2.32% | -1.1% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $139,724,376 | -2.9% | 2,646,295 | -0.6% | 2.25% | +9.6% |
| RVMD | Sell | REVOLUTION MEDICINES INC | $130,691,120 | +2.9% | 4,721,500 | -0.5% | 2.11% | +16.3% |
| SYK | Sell | STRYKER CORPORATION | $129,970,765 | -10.7% | 475,613 | -0.3% | 2.09% | +0.9% |
| INSM | Sell | INSMED INC | $79,859,059 | +14.7% | 3,162,735 | -4.2% | 1.29% | +29.5% |
| BDX | Sell | BECTON DICKINSON & CO | $78,652,582 | -11.8% | 304,230 | -9.9% | 1.27% | -0.4% |
| OPCH | Sell | OPTION CARE HEALTH INC | $73,896,879 | -0.6% | 2,284,293 | -0.1% | 1.19% | +12.4% |
| EW | Sell | EDWARDS LIFESCIENCES CORP | $71,043,661 | -27.4% | 1,025,457 | -1.2% | 1.14% | -18.0% |
| DXCM | Sell | DEXCOM INC | $63,978,889 | -34.6% | 685,733 | -10.0% | 1.03% | -26.1% |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $60,497,320 | -39.7% | 7,245,188 | -3.9% | 0.98% | -31.9% |
| MOH | Sell | MOLINA HEALTHCARE INC | $51,950,236 | +4.9% | 158,438 | -3.6% | 0.84% | +18.6% |
| EXEL | Sell | EXELIXIS INC | $51,913,961 | +7.2% | 2,375,925 | -6.2% | 0.84% | +21.0% |
| ALGN | Sell | ALIGN TECHNOLOGY INC | $50,953,634 | -15.8% | 166,886 | -2.5% | 0.82% | -4.9% |
| SWAV | Sell | SHOCKWAVE MED INC | $50,626,949 | -34.4% | 254,279 | -6.0% | 0.82% | -25.9% |
| MDT | Sell | MEDTRONIC PLC | $50,267,313 | -59.5% | 641,492 | -54.5% | 0.81% | -54.3% |
| BIO | Sell | BIO RAD LABS INCcl a | $48,150,589 | -5.6% | 134,330 | -0.2% | 0.78% | +6.6% |
| VEEV | Sell | VEEVA SYS INC | $45,593,145 | -14.9% | 224,100 | -17.3% | 0.74% | -3.8% |
| CRL | Sell | CHARLES RIV LABS INTL INC | $44,946,445 | -32.0% | 229,342 | -27.1% | 0.72% | -23.2% |
| LLY | Sell | ELI LILLY & CO | $43,798,117 | -1.9% | 81,541 | -14.3% | 0.71% | +10.8% |
| PODD | Sell | INSULET CORP | $42,162,617 | -54.8% | 264,359 | -18.3% | 0.68% | -49.0% |
| ARVN | Sell | ARVINAS INC | $41,738,928 | -20.9% | 2,125,200 | -0.1% | 0.67% | -10.8% |
| CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $40,778,376 | -19.2% | 898,400 | -0.1% | 0.66% | -8.8% |
| HCA | Sell | HCA HEALTHCARE INC | $38,285,065 | -21.4% | 155,643 | -3.0% | 0.62% | -11.2% |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $34,460,293 | -3.7% | 266,226 | -7.8% | 0.56% | +8.6% |
| DHR | Sell | DANAHER CORPORATION | $33,873,837 | -23.2% | 136,533 | -25.7% | 0.55% | -13.2% |
| TMO | Sell | THERMO FISHER SCIENTIFIC INC | $33,644,108 | -32.9% | 66,468 | -30.8% | 0.54% | -24.2% |
| ATRC | Sell | ATRICURE INC | $32,743,128 | -11.4% | 747,560 | -0.1% | 0.53% | +0.2% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $30,958,090 | -1.0% | 349,888 | -3.0% | 0.50% | +11.9% |
| HCM | Sell | HUTCHMED CHINA LTDsponsored ads | $30,584,761 | +41.2% | 1,802,963 | -0.1% | 0.49% | +59.5% |
| IQV | Sell | IQVIA HLDGS INC | $30,539,535 | -16.2% | 155,220 | -4.3% | 0.49% | -5.4% |
| GMED | Sell | GLOBUS MED INCcl a | $30,267,385 | -21.5% | 609,615 | -5.9% | 0.49% | -11.3% |
| MRK | Sell | MERCK & CO INC | $30,050,693 | -15.1% | 291,896 | -4.8% | 0.48% | -4.2% |
| TMDX | Sell | TRANSMEDICS GROUP INC | $29,386,351 | -42.9% | 536,737 | -12.4% | 0.47% | -35.6% |
| OM | Sell | OUTSET MED INC | $26,203,718 | -61.7% | 2,408,430 | -23.0% | 0.42% | -56.7% |
| PRVA | Sell | PRIVIA HEALTH GROUP INC | $24,269,094 | -17.2% | 1,055,178 | -6.0% | 0.39% | -6.5% |
| BEAM | Sell | BEAM THERAPEUTICS INC | $16,710,445 | -24.7% | 694,821 | -0.1% | 0.27% | -15.1% |
| SUPN | Sell | SUPERNUS PHARMACEUTICALS INC | $16,007,142 | -18.1% | 580,600 | -10.7% | 0.26% | -7.5% |
| SRRK | Sell | SCHOLAR ROCK HLDG CORP | $15,179,268 | -5.9% | 2,137,925 | -0.1% | 0.24% | +6.5% |
| INSP | Sell | INSPIRE MED SYS INC | $13,963,826 | -88.0% | 70,368 | -80.3% | 0.22% | -86.4% |
| GBIO | Sell | GENERATION BIO CO | $13,708,733 | -31.2% | 3,617,080 | -0.1% | 0.22% | -22.2% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $12,294,199 | +4.8% | 14,939 | -8.5% | 0.20% | +18.6% |
| TXG | Sell | 10X GENOMICS INC | $12,145,320 | -33.0% | 294,432 | -9.3% | 0.20% | -24.3% |
| RMD | Sell | RESMED INC | $11,341,038 | -47.2% | 76,696 | -22.0% | 0.18% | -40.2% |
| PHR | Sell | PHREESIA INC | $10,816,449 | -45.4% | 579,039 | -9.3% | 0.17% | -38.5% |
| OMCL | Sell | OMNICELL COM | $10,777,126 | -50.1% | 239,279 | -18.4% | 0.17% | -43.5% |
| FATE | Sell | FATE THERAPEUTICS INC | $10,285,347 | -55.5% | 4,851,579 | -0.1% | 0.17% | -49.7% |
| AMED | Sell | AMEDISYS INC | $9,936,546 | -53.6% | 106,387 | -54.6% | 0.16% | -47.7% |
| ILMN | Sell | ILLUMINA INC | $9,888,278 | -37.2% | 72,030 | -14.3% | 0.16% | -29.3% |
| DOCS | Sell | DOXIMITY INCcl a | $8,476,478 | -44.5% | 399,457 | -11.0% | 0.14% | -37.2% |
| GILD | Sell | GILEAD SCIENCES INC | $8,044,809 | -7.3% | 107,350 | -4.7% | 0.13% | +4.8% |
| TDOC | Sell | TELADOC HEALTH INC | $6,611,515 | -33.4% | 355,649 | -9.3% | 0.11% | -24.6% |
| MRSN | Sell | MERSANA THERAPEUTICS INC | $6,627,654 | -61.4% | 5,218,625 | -0.0% | 0.11% | -56.3% |
| AZN | Sell | ASTRAZENECA PLCsponsored adr | $5,726,045 | -6.5% | 84,600 | -1.2% | 0.09% | +5.7% |
| RDY | Sell | DR REDDYS LABS LTDadr | $5,414,381 | -6.4% | 80,200 | -12.5% | 0.09% | +4.8% |
| BIIB | Sell | BIOGEN INC | $4,449,871 | -39.0% | 17,314 | -32.4% | 0.07% | -30.8% |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $4,120,179 | -29.6% | 4,204,264 | -0.1% | 0.07% | -20.5% |
| NVRO | Sell | NEVRO CORP | $3,808,847 | -31.4% | 198,171 | -9.3% | 0.06% | -22.8% |
| OLK | Sell | OLINK HLDG ABsponsored ads | $3,204,526 | -28.7% | 217,256 | -9.3% | 0.05% | -18.8% |
| KOS | Sell | KOSMOS ENERGY LTD | $2,323,120 | +21.8% | 284,000 | -10.8% | 0.04% | +37.0% |
| GH | Sell | GUARDANT HEALTH INC | $2,208,921 | -24.9% | 74,525 | -9.3% | 0.04% | -14.3% |
| BBIO | Sell | BRIDGEBIO PHARMA INC | $2,075,319 | +24.5% | 78,700 | -18.8% | 0.03% | +37.5% |
| KRYS | Sell | KRYSTAL BIOTECH INC | $1,450,000 | -31.4% | 12,500 | -30.6% | 0.02% | -23.3% |
| AKRO | Sell | AKERO THERAPEUTICS INC | $1,264,500 | -0.1% | 25,000 | -7.7% | 0.02% | +11.1% |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $1,166,721 | -46.7% | 6,900 | -31.7% | 0.02% | -38.7% |
| ZTS | Sell | ZOETIS INCcl a | $1,124,259 | +0.5% | 6,462 | -0.5% | 0.02% | +12.5% |
| ABBV | Sell | ABBVIE INC | $709,973 | -14.6% | 4,763 | -22.9% | 0.01% | -8.3% |
| ETNB | Sell | 89BIO INC | $605,248 | -51.0% | 39,200 | -39.9% | 0.01% | -44.4% |
| SEER | Sell | SEER INC | $272,771 | -53.1% | 123,426 | -9.3% | 0.00% | -50.0% |
| DGX | Sell | QUEST DIAGNOSTICS INC | $161,343 | -40.9% | 1,324 | -31.8% | 0.00% | -25.0% |
| GRCL | Sell | GRACELL BIOTECHNOLOGIES INCsponsored ads | $109,440 | -80.3% | 38,000 | -73.9% | 0.00% | -75.0% |
| KZR | Exit | KEZAR LIFE SCIENCES INC | $0 | – | -10,000 | -100.0% | 0.00% | – |
| ABCM | Exit | ABCAM PLCads | $0 | – | -2,573 | -100.0% | -0.00% | – |
| JMIA | Exit | JUMIA TECHNOLOGIES AGsponsored ads | $0 | – | -18,000 | -100.0% | -0.00% | – |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -33,000 | -100.0% | -0.01% | – |
| ARWR | Exit | ARROWHEAD PHARMACEUTICALS IN | $0 | – | -20,700 | -100.0% | -0.01% | – |
| Exit | DICE THERAPEUTICS INC | $0 | – | -18,200 | -100.0% | -0.01% | – | |
| FDMT | Exit | 4D MOLECULAR THERAPEUTICS IN | $0 | – | -45,000 | -100.0% | -0.01% | – |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -55,600 | -100.0% | -0.02% | – |
| DNLI | Exit | DENALI THERAPEUTICS INC | $0 | – | -44,050 | -100.0% | -0.02% | – |
| AMWL | Exit | AMERICAN WELL CORPcl a | $0 | – | -953,613 | -100.0% | -0.03% | – |
| Exit | SIGHT SCIENCES INC | $0 | – | -286,284 | -100.0% | -0.03% | – | |
| MTEM | Exit | MOLECULAR TEMPLATES INC | $0 | – | -11,230,003 | -100.0% | -0.08% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -213,434 | -100.0% | -0.14% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- BB Biotech AG #1
- Bellevue Asset Management AG #2
- Bellevue Asset Management (UK) Ltd. #3
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IONIS PHARMACEUTICALS INC | 31 | Q3 2023 | 9.3% |
| Vertex Pharmaceuticals Incorporated | 31 | Q3 2023 | 5.9% |
| NEUROCRINE BIOSCIENCES INC | 31 | Q3 2023 | 5.7% |
| Incyte Corporation | 31 | Q3 2023 | 5.4% |
| INTUITIVE SURGICAL INC | 31 | Q3 2023 | 4.7% |
| ABBOTT LABS | 31 | Q3 2023 | 4.6% |
| ELEVANCE HEALTH INC | 31 | Q3 2023 | 4.3% |
| UnitedHealth Group Incorporated | 31 | Q3 2023 | 3.6% |
| ALNYLAM PHARMACEUTICALS INC | 31 | Q3 2023 | 3.7% |
| Boston Scientific Corporation | 31 | Q3 2023 | 2.5% |
View Bellevue Group AG's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View Bellevue Group AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.